[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555782":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":35,"locations":44,"responsibleParty":67,"collaborators":10,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":10,"enrollmentInfo":78,"targetDuration":81,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":88,"overallStatus":46,"whyStopped":10,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"University Medical Center Ho Chi Minh City (UMC)","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Heart failure with reduced or mildly reduced ejection fraction",null,[12],"Drug: Optimal treatment",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DRUG","Optimal treatment","Optimal treatment using current National Guidelines for the diagnosis and treatment of chronic heart failure",[9],[20,24,26,30,33],{"name":21,"affiliation":22,"role":23},"Cong Thanh Nguyen, MD, MSc","University Medical Center Ho Chi Minh City","STUDY_CHAIR",{"name":25,"affiliation":22,"role":23},"Thanh Hai Nam Phan, MD, MSc",{"name":27,"affiliation":28,"role":29},"Quang Binh Truong, Professor","University of Medicine and Pharmacy at Ho Chi Minh City","STUDY_DIRECTOR",{"name":31,"affiliation":28,"role":32},"Hoang Vu Vu, PhD","PRINCIPAL_INVESTIGATOR",{"name":34,"affiliation":22,"role":23},"Dang Duy Quang Pham, MD, MSc",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":10,"email":40},"Hoang Vu Vu, MD, PhD","CONTACT","+84908431304","vu.vh@umc.edu.vn",{"name":34,"role":38,"phone":42,"phoneExt":10,"email":43},"+84937134599","quang.pdd@umc.edu.vn",[45],{"facility":22,"status":46,"city":47,"state":10,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"RECRUITING","Ho Chi Minh City","700000","Vietnam","VN",{"type":52,"coordinates":53},"Point",[54,55],106.62965,10.82302,{"lat":55,"lon":54},[58,59,60,62,63,65,66],{"name":37,"role":38,"phone":39,"phoneExt":10,"email":40},{"name":34,"role":38,"phone":42,"phoneExt":10,"email":43},{"name":21,"role":61,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"name":25,"role":61,"phone":10,"phoneExt":10,"email":10},{"name":64,"role":61,"phone":10,"phoneExt":10,"email":10},"Thi Diem Thuy Vo, MD, MSc",{"name":34,"role":61,"phone":10,"phoneExt":10,"email":10},{"name":37,"role":32,"phone":10,"phoneExt":10,"email":10},{"type":68,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100555782","demographic-clinical-biological-treatment-characteristics-and-cardiovascular-events-of-patients-with-heart-failure-in-vietnam-a-multicenter-prospective-observational-study-100555782",false,"NCT06516562","Demographic, Clinical, Biological, Treatment Characteristics and Cardiovascular Events of Patients With Heart Failure in Vietnam: a Multicenter Prospective Observational Study","MCR-HF","Inclusion Criteria:\n\n* Patients aged 18 years and older\n* Diagnosed with heart failure at the time of discharge\n* Have an ejection fraction (based on imaging modalities such as echocardiography or cardiac MRI) recorded closest to the time of discharge, showing a left ventricular ejection fraction of less than 50%\n\nExclusion Criteria:\n\n* Patients and their relatives do not have means of communication with healthcare staff (phone, computer, messaging, etc.)\n* Patients do not reside in Vietnam after discharge","ALL","18 Years",{"count":79,"type":80},2500,"ESTIMATED","12 Months","OBSERVATIONAL","Describe the clinical characteristics, paraclinical features, and treatment during hospitalization, as well as at 1, 3, and 12 months post-discharge, of heart failure patients at selected cardiovascular centers in Vietnam.",[85,86,87],"Heart Failure","Heart Failure With Reduced Ejection Fraction","Heart Failure With Mid Range Ejection Fraction",[89,90,91,92,93,94,95],"Patient registry","Heart failure","Prospective Observational Study","Demographic","Treatment characteristics","Prognosis","MACE","2024-12-03",{"date":98,"type":99},"2024-12-06","ACTUAL",{"date":101,"type":99},"2023-08-01",{"date":103,"type":80},"2028-06-01",{"name":5,"class":6},1]